Sponsor study identifier
interventional
10
1 country
1
Study Start
July 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Mesenchymal stem cells (MSCs) have been reported to be effective to prevent alveolar growth arrest in experimental bronchopulmonary dysplasia (BPD). The aim is to treat the extremely premature infant with severe BPD to establish whether intratracheal instillation of umbilical cord-derived MSCs (ucMSCs) is safe and effective as a rescue treatment for severe BPD.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2010
Date type not reportedThis date has not been verified as actual or estimated.
September 11, 2010
Actual (reported)September 23, 2010
Actual (reported)June 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The relations between the cytokine concentrations in the BAL fluid and PAP.
To examine the relations between the cytokine concentrations in the BAL fluid and PAP.
Up to 20 weeks
The severity score of BPD ranging from 0 to 6 on the serial chest radiographs
6 months to 1 year
the ucMSCs suspension(3× 106 cells per kg of the patient's weight) will be instilled through a 6 French end-hole catheter inserted into the infant's endotracheal tube
Normal saline
the ucMSCs suspension(3× 106 cells per kg of the patient's weight) will be instilled through a 6 French end-hole catheter inserted into the infant's endotracheal tube
the same amount of ucMSCs suspension will be instilled through a 6 French end-hole catheter inserted into the infant's endotracheal tube
China Medical University Hospital
Taichung, 404, Taiwan
Bai-Horng Su, MD, PhD
China Medical University Hospital
First Submitted
September 11, 2010
First Posted
September 23, 2010
Study Start
July 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2012
Estimated (date passed)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 23, 2010
Record last verified: 2010-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: